Active Ingredient Benralizumab
Active Ingredient Details
What is the usage for Benralizumab?
Benralizumab is used along with other medications to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.
How many products in the NDC database contain Benralizumab?
The NDC database has 5 products with the active ingredient Benralizumab. The following table lists all the products that have this active ingredient.
NDC Products with Benralizumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0310-1730 | Proprietary Name: Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 0310-1830 | Proprietary Name: Fasenra | Benralizumab | Injection, Solution | Subcutaneous | Astrazeneca Pharmaceuticals Lp | ACTIVE | |
| 0310-2830 | Proprietary Name: | Benralizumab | Liquid | Astrazeneca Pharmaceuticals Lp | ACTIVE | ||
| 17228-2730 | Proprietary Name: | Benralizumab | Injection, Solution | Astrazeneca Ab | ACTIVE | ||
| 61434-018 | Proprietary Name: | Benralizumab | Injection, Solution | Catalent Indiana, Llc | ACTIVE |